HSKA - BofA/ML cuts view on Karyopharm in premarket analyst action February, 27 2019 08:01 AM Heska Corporation Heska (NASDAQ:HSKA) downgraded to Hold at Benchmark. More news on: Heska Corporation, Karyopharm Therapeutics Inc., Mylan Inc, Healthcare stocks news, Stocks on the move, , Read more ...